Clinical Trial Update: Intranasal Challenge of Healthy Adults With Respiratory Syncytial Virus (RSV) [Phase 1]

View source ↗

Summary

A Phase 1 intranasal challenge trial of respiratory syncytial virus in healthy adults sponsored by MedImmune was terminated; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Snippet

Sponsor: MedImmune LLC | Conditions: RSV Infection | Phase 1 | Status: TERMINATED | Results posted: 2017-07-21